US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuveen Minnesota Municipal Income Fund

11.35

+0.00390.03%

Volume:8.62K

Turnover:98.01K

Market Cap:65.68M

PE:-4.88

High:11.41

Open:11.41

Low:11.35

Close:11.35

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Nuveen Minnesota Quality Municipal Income Fund Releases Latest Distribution Report

Press Release: FatPipe Announces Leadership Team Appointments as It Accelerates Expansion Following Nasdaq Listing

Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry

Press Release: Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NMS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMS\",,,,,undefined,":{"symbol":"NMS","market":"US","secType":"STK","nameCN":"Nuveen Minnesota Municipal Income Fund","latestPrice":11.3501,"timestamp":1750273114935,"preClose":11.3462,"halted":0,"volume":8622,"delay":0,"floatShares":0,"shares":5787057,"eps":-2.32397,"marketStatus":"Trading","change":0.0039,"latestTime":"06-18 15:25:10 EDT","open":11.41,"high":11.41,"low":11.35,"amount":98014.473522,"amplitude":0.005288,"askPrice":11.37,"askSize":100,"bidPrice":11.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.32397,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750276800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":11.3462,"dividendRate":0.077532,"postHourTrading":{"tag":"盘后","latestPrice":11.3462,"preClose":11.3462,"latestTime":"16:04 EDT","volume":10,"amount":113.4924,"timestamp":1750190650102},"volumeRatio":0.787278},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMS\",,,,,undefined,":{"symbol":"NMS","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.787278,"shares":5787057,"dividePrice":0.88,"high":11.41,"amplitude":0.005288,"preClose":11.3462,"low":11.35,"week52Low":11.27,"pbRate":"--","week52High":13.76,"institutionHeld":0,"latestPrice":11.3501,"eps":-2.32397,"divideRate":0.077532,"volume":8622,"delay":0,"ttmEps":-2.32397,"open":11.41,"prevYearClose":12.34,"prevWeekClose":11.35,"prevMonthClose":11.38,"prevQuarterClose":12.0025,"fiveDayClose":11.4519,"twentyDayClose":11.63,"sixtyDayClose":12.24},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NMS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539203160","title":"Nuveen Minnesota Quality Municipal Income Fund Releases Latest Distribution Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2539203160","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539203160?lang=en_us&edition=fundamental","pubTime":"2025-05-31 05:31","pubTimestamp":1748640674,"startTime":"0","endTime":"0","summary":"Nuveen Minnesota Quality Municipal Income Fund released its latest report on May 30, 2025, providing shareholders with information on the fund's distributions as of April 30, 2025. The notice, issued for informational purposes, outlines the fund's distribution policy, which includes regular monthly cash distributions to common shareholders. The report highlights that the fund intends to distribute all or substantially all of its net investment income annually and may distribute realized capital gains at least once per year. Shareholders are encouraged to access further details on Nuveen's official website. No immediate action is required from shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuveen Minnesota Quality Municipa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL9Pww6W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NIM","NMS"],"gpt_icon":0},{"id":"2534453974","title":"Press Release: FatPipe Announces Leadership Team Appointments as It Accelerates Expansion Following Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2534453974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534453974?lang=en_us&edition=fundamental","pubTime":"2025-05-10 00:58","pubTimestamp":1746809880,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, May 9, 2025 /PRNewswire/ -- FatPipe, Inc. FatPipe, Inc.  , a pioneer in enterprise-class, application-aware, secure software-defined wide area network  solutions that provide the highest levels of reliability, security, and optimization for Wide Area Networks , today announced the appointment of its full executive management team as it continues to build on the momentum of its recent Nasdaq listing, scaling operations globally to meet increasing demand for secure, reliable, and optimized enterprise connectivity.\"While our innovative solutions remain the foundation of our success, our world-class leadership team is a key driver of FatPipe's competitive advantage,\" said Dr. Ragula Bhaskar, Chairman and CEO of FatPipe. \"With decades of combined expertise in networking technology, cybersecurity, sales, and finance, we have built a leadership team ready to drive FatPipe's next phase of growth. Together, we are focused on expanding our talent base and seizing opportunities in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","FATN","IE00B3QW5Z07.USD","BK4120","TISI","BK4023","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","NMS","LU2210150020.SGD","NQmain","BK4112","IE00BKPKM429.USD","BK4585",".IXIC"],"gpt_icon":0},{"id":"2530699827","title":"Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry","url":"https://stock-news.laohu8.com/highlight/detail?id=2530699827","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530699827?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:05","pubTimestamp":1745525100,"startTime":"0","endTime":"0","summary":"Post-hoc analysis of higher risk older adults showed substantial and sustained improvements in tardive dyskinesia symptoms with no new treatment-emergent adverse events of clinical concern. SAN DIEGO, April 24, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc.  today announced publication of a post-hoc analysis from two 48-week studies, the KINECT 3 extension and KINECT 4, demonstrating the long-term safety profile and robust efficacy of INGREZZA  capsules in adults aged 65 years and older with tardive dyskinesia  inThe Journal of Clinical Psychiatry. This represents the first and only published peer-reviewed analysis of a vesicular monoamine transporter 2 inhibitor for the treatment ofTD in older adults , a group at higher risk for TD and associated consequences.\"This analysis, the first and only of its kind in a peer-reviewed publication, addresses an important gap in research on this potentially vulnerable population,\" said Eiry W. Roberts, M.D., Chief Medical Officer, Neurocrine Bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-publishes-analysis-showing-200500549.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-publishes-analysis-showing-200500549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0820561818.USD","LU1674673428.USD","LU1929549753.HKD","IE00BSNM7G36.USD","LU0823416689.USD","BK4534","LU2756315318.SGD","BK4550","IE00BWXC8680.SGD","LU1162221912.USD","BK4581","LU0234572021.USD","BK4139","BK4533","NMS","IE00B1XK9C88.USD","LU1989772840.SGD","TD","LU1914381329.SGD","NBIX","BK4567","LU0820562030.AUD","LU1093756168.USD","BK4585","LU1989772923.USD","HD","LU1551013425.SGD","SG9999001440.SGD","LU0943347566.SGD","LU1093756325.SGD","LU0109394709.USD","LU1069344957.HKD","LU1551013342.USD","LU2065171311.SGD","LU1778281490.HKD","LU0354030438.USD","BK4588","LU0889565916.HKD","BK4207","IE00BZ1G4Q59.USD","LU0823411888.USD","LU0320765992.SGD","LU2324357040.USD","LU0868494617.USD","BK4083","LU1035775433.USD","LU0354030511.USD","BK4504","LU2065170008.USD","LU2065169927.USD"],"gpt_icon":0},{"id":"2524149807","title":"Press Release: Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2524149807","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524149807?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:44","pubTimestamp":1743597840,"startTime":"0","endTime":"0","summary":"Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership. Advances Company's industry-leading portfolio in mental health with addition of CAPLYTA , the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive therapy and monotherapy; also approved for the treatment of schizophrenia in adults. sNDA submitted to U.S. FDA for CAPLYTA as adjunctive treatment for major depressive disorder; if approved, has potential to become a new standard of care for most common depressive disorders. Addition of CAPLYTA strengthens J&J's robust lineup of therapies with $5 billion+ potential in peak year sales , further solidifying sales growth above analyst expectations now through the remainder of the decade. Johnson & Johnson  today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson & Johnson and will operate as a business unit within Johnso","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","IE00BGHQF631.EUR","LU1221951046.USD","SG9999001440.SGD","IE00BVYPNV92.GBP","IE00B3PB1722.GBP","LU2430703251.USD","LU0122379950.USD","BK4559","IE00B7SZLL34.SGD","LU0109394709.USD","LU1061106388.HKD","LU1162221912.USD","IE00B3T34201.USD","LU1032466523.USD","LU1914381329.SGD","BK4588","BK4534","LU0098860793.USD","LARK","BK4211","LU0320765646.SGD","LU1929549753.HKD","TD","LU0058720904.USD","LU1023059063.AUD","LU0792757196.USD","BK4566","ITCI","JNJ","BK4585","IE0034235303.USD","IE0002270589.USD","NMS","IE00BDGV0183.EUR","LU0345770308.USD","LU0345770993.USD","LU0889566641.SGD","IE00BJJMRZ35.SGD","R","SG9999002224.SGD","LU1074936037.SGD","LU2430703178.SGD","LU2133065610.SGD","LU0234572021.USD","LU1066051498.USD","LU1244550494.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMS\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"NMS","amount":0.0735,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-07-01"},{"date":"2025-05-15","symbol":"NMS","amount":0.0735,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-15","defaultRemindTime":1747315800000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-02","payableDate":"2025-05-15","currency":"USD","dateTimestamp":1747281600000,"payDate":"2025-06-02"},{"date":"2025-04-15","symbol":"NMS","amount":0.0735,"announcedDate":"2025-04-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-15","defaultRemindTime":1744723800000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-15","currency":"USD","dateTimestamp":1744689600000,"payDate":"2025-05-01"},{"date":"2025-03-14","symbol":"NMS","amount":0.0735,"announcedDate":"2025-03-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-14","defaultRemindTime":1741959000000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-14","currency":"USD","dateTimestamp":1741924800000,"payDate":"2025-04-01"},{"date":"2025-02-14","symbol":"NMS","amount":0.0735,"announcedDate":"2025-02-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"Nuveen Minnesota Municipal Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-03","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-03-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMS\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-13","recordDate":"2015-07-15","paymentDate":"2015-08-03","value":0.069,"currency":"USD"},{"executeDate":"2015-08-12","recordDate":"2015-08-14","paymentDate":"2015-09-01","value":0.069,"currency":"USD"},{"executeDate":"2015-09-11","recordDate":"2015-09-15","paymentDate":"2015-10-01","value":0.0665,"currency":"USD"},{"executeDate":"2015-10-13","recordDate":"2015-10-15","paymentDate":"2015-11-02","value":0.0665,"currency":"USD"},{"executeDate":"2015-11-10","recordDate":"2015-11-13","paymentDate":"2015-12-01","value":0.0665,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMS\",market:\"US\",delay:false,,,undefined,":{}}}